# Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery

> **NCT06785090** · PHASE4 · COMPLETED · sponsor: **Inas Abd** · enrollment: 87 (actual)

## Conditions studied

- Cataract
- Cystoid Macular Edema After Phacoemulsification

## Interventions

- **DRUG:** Bromfenac
- **DRUG:** Moxifloxacin 0.5% ophthalmic solution
- **DRUG:** Dexamethasone phosphate 0.1%

## Key facts

- **NCT ID:** NCT06785090
- **Lead sponsor:** Inas Abd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06785090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06785090, "Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06785090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*